The impact of drug production, trafficking and abuse in Iran is considerable. Of primary concern are opiates – including opium and heroin – and methamphetamines, particularly ‘crystal meth.’
Drugs cause adverse effects on public health, including drug-related morbidity and mortality, and the associated risk of drug dependency and HIV infection. Another cost is the burden on the economy and society caused by lost productivity and the depletion of youth potential.
Under the UNDAF, the UN has supported the development and implementation of effective, coordinated drug prevention programmes, with a focus on families, communities, educational centres and the workplace, prioritizing the most-at-risk population.
Focus has also included enhancing national capacities for effective treatment and rehabilitation programmes for people affected by drugs and promoting evidence-based HIV prevention, treatment, care and control programmes among drug users.
In addition, the UN’s work has strengthened national capacities to combat drug trafficking.
The UN has worked towards four main outcomes under the drug control and prevention priority area:
• To design and implement evidence and community based drug prevention programmes.
• To develop and implement drug awareness campaigns, including in universities and schools.
• Support community-based capacity building (training and support systems development).
• Support the needs of most at-risk populations.
The Iran Project is not responsible for the content of quoted articles.